Podcast Episodes
Back to Search
RSV in Older Adults: Epidemiology and Risk Factors
Episode 168
In this episode, Dexter James Wiseman, MD, discusses the epidemiology and risk factors for RSV in older adults, including:
OverviewDisease burden base…3 years, 10 months ago
Adult HBV Vaccination: Identifying Individuals at Risk for Reduced Seroprotection
Episode 169
In this episode, learn about the importance of identifying adults at risk for reduced hepatitis B virus (HBV) seroprotection and applying current HBV…
3 years, 10 months ago
Adult HBV Vaccination: Overcoming Gaps to Lessen the Burden and Impact of HBV
Episode 167
In this episode, learn about the importance of hepatitis B virus (HBV) vaccination in adults. Listen as Robert G. Gish, MD, discusses key data on the…
3 years, 10 months ago
Increasing Awareness of Hepatitis Delta
Episode 159
Hepatitis delta virus (HDV) is the most severe form of viral hepatitis, yet many patients go undiagnosed. Increasing HDV awareness is an important st…
3 years, 10 months ago
Why Everyone Should Be Screened for HCV and Treated If They Have It: Conversations Between Patient and Physician
Episode 165
In this episode, Norah Terrault, MD, MPH, and a patient who has been cured of hepatitis C virus (HCV) infection discuss the importance of universal H…
3 years, 10 months ago
Key Decisions in HIV Care: Considering Novel Therapies for HIV
Episode 164
In this episode from the series “Key Decisions in HIV Care,” Cristina Mussini, MD, and William R. Short, MD, MPH, AAHIVS, discuss novel therapies for…
3 years, 10 months ago
A Model Intervention: Aiming for HCV Elimination in HIV-Positive MSM
Episode 163
In this podcast, Dr Dominique Laurent Braun discusses his micro-elimination program, the Swiss HCVree trial, designed to prevent hepatitis C virus (H…
3 years, 10 months ago
COVID-19: Which Drug, When, and Why? Antiviral Agents
Episode 162
Antiviral agents continue to be effective against different strains of SARS-CoV-2 when used early in the disease course. In this episode, learn about…
3 years, 10 months ago
COVID-19: Which Drug, When, and Why? Monoclonal Antibody Treatments
Episode 161
The place of monoclonal antibodies in COVID-19 is changing. In this episode, learn about their role in prophylaxis of patients who are at high risk o…
3 years, 11 months ago
How Stigma and Socioeconomic Barriers Impede HCV Care: Conversations Between Patient and Physician
Episode 160
In this episode, Oluwaseun Falade-Nwulia, MBBS, MPH, and a patient with previous injection drug use who has been cured of HCV infection discuss criti…
3 years, 11 months ago